Armis Advisers
BMY icon

Armis Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Armis Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$659K Buy
11,447
+2,221
+24% +$140K 0.06% 229
2026
Q2 		$523K Sell
9,226
-256
-3% -$14.7K 0.05% 267
2026
Q1 		$535K Sell
9,482
-136
-1% -$7.93K 0.05% 231
2025
Q4 		$553K Buy
9,618
+5,166
+116% +$249K 0.06% 215
2025
Q3 		$205K Buy
+4,452
New +$208K 0.02% 307

Other funds holding BMY

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Armis Advisers's BMY Position: Q3 2026 in Review

Armis Advisers increased its Bristol-Myers Squibb (BMY) stake by 24% in Q3 2026, buying an estimated $140K and bringing the position to 11,447 shares worth $659K. The position accounts for 0.06% of the portfolio, ranked #229.

Armis Advisers first reported a position in BMY in Q3 2025 and has held it in 5 quarters since. 1,443 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Armis Advisers held 11,447 shares of Bristol-Myers Squibb worth $659K as of Q3 2026.
  • Armis Advisers bought 2,221 Bristol-Myers Squibb shares in Q3 2026, an estimated $140K.
  • Bristol-Myers Squibb made up 0.06% of Armis Advisers's portfolio in Q3 2026, its #229 holding.
  • Armis Advisers first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 5 quarters since.
  • 1,443 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.